121 related articles for article (PubMed ID: 34973538)
1. Identification of a novel broad-spectrum endolysin, Ply0643, with high antibacterial activity in mouse models of streptococcal bacteriaemia and mastitis.
Liu G; Zhang S; Gao T; Mao Z; Shen Y; Pan Z; Guo C; Yu Y; Yao H
Res Vet Sci; 2022 Mar; 143():41-49. PubMed ID: 34973538
[TBL] [Abstract][Full Text] [Related]
2. Synergistic streptococcal phage λSA2 and B30 endolysins kill streptococci in cow milk and in a mouse model of mastitis.
Schmelcher M; Powell AM; Camp MJ; Pohl CS; Donovan DM
Appl Microbiol Biotechnol; 2015 Oct; 99(20):8475-86. PubMed ID: 25895090
[TBL] [Abstract][Full Text] [Related]
3. Streptococcus suis prophage lysin as a new strategy for combating streptococci-induced mastitis and Streptococcus suis infection.
Li XX; Zhang FQ; Wang S; Duan XC; Hu DY; Gao DY; Tao P; Li XM; Qian P
J Antimicrob Chemother; 2023 Mar; 78(3):747-756. PubMed ID: 36659862
[TBL] [Abstract][Full Text] [Related]
4. A novel prophage lysin Ply5218 with extended lytic activity and stability against Streptococcus suis infection.
Zhang H; Zhang C; Wang H; Yan YX; Sun J
FEMS Microbiol Lett; 2016 Sep; 363(18):. PubMed ID: 27481700
[TBL] [Abstract][Full Text] [Related]
5. A novel endolysin disrupts Streptococcus suis with high efficiency.
Ji W; Huang Q; Sun L; Wang H; Yan Y; Sun J
FEMS Microbiol Lett; 2015 Dec; 362(24):fnv205. PubMed ID: 26534896
[TBL] [Abstract][Full Text] [Related]
6. Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections.
Tang F; Li D; Wang H; Ma Z; Lu C; Dai J
Appl Environ Microbiol; 2015 Nov; 81(21):7377-84. PubMed ID: 26253669
[TBL] [Abstract][Full Text] [Related]
7. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.
Gilmer DB; Schmitz JE; Euler CW; Fischetti VA
Antimicrob Agents Chemother; 2013 Jun; 57(6):2743-50. PubMed ID: 23571534
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia.
Oechslin F; Daraspe J; Giddey M; Moreillon P; Resch G
Antimicrob Agents Chemother; 2013 Dec; 57(12):6276-83. PubMed ID: 24100496
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial effect of synthetic ultra-short lipopeptide on Streptococcus agalactiae and its active on bacterial mastitis in mice.
Peng J; Lu Q; Liu X; Deng Y; Shang T; Yuan L; Zhang H; Zeng Q
Biochem Biophys Res Commun; 2022 Apr; 601():153-159. PubMed ID: 35247769
[TBL] [Abstract][Full Text] [Related]
10.
Xi H; Fu Y; Chen C; Feng X; Han W; Gu J; Ji Y
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068990
[No Abstract] [Full Text] [Related]
11. Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands.
Schmelcher M; Powell AM; Becker SC; Camp MJ; Donovan DM
Appl Environ Microbiol; 2012 Apr; 78(7):2297-305. PubMed ID: 22286996
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel broad-spectrum endolysin PlyD4 encoded by a highly conserved prophage found in Aeromonas hydrophila ST251 strains.
Wang C; Shi S; Wei M; Luo Y
Appl Microbiol Biotechnol; 2022 Jan; 106(2):699-711. PubMed ID: 34985567
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of extended binding affinity of prophage lysin PlyARI against Streptococcus suis infection.
Xiao Y; Chen R; Li M; Qi Z; Yu Y; Pan Z; Yao H; Feng Z; Zhang W
Arch Microbiol; 2021 Oct; 203(8):5163-5172. PubMed ID: 34338822
[TBL] [Abstract][Full Text] [Related]
14. A novel lysin Ply1228 provides efficient protection against Streptococcus suis type 2 infection in a murine bacteremia model.
Wang Z; Liu X; Shi Z; Zhao R; Ji Y; Tang F; Guan Y; Feng X; Sun C; Lei L; Han W; Du XD; Gu J
Vet Microbiol; 2022 May; 268():109425. PubMed ID: 35397385
[TBL] [Abstract][Full Text] [Related]
15. The PlyB Endolysin of Bacteriophage vB_BanS_Bcp1 Exhibits Broad-Spectrum Bactericidal Activity against
Schuch R; Pelzek AJ; Nelson DC; Fischetti VA
Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30850428
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the antibacterial activity of tilmicosin-SLN against
Zhu L; Cao X; Xu Q; Su J; Li X; Zhou W
Int J Nanomedicine; 2018; 13():4747-4755. PubMed ID: 30147316
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics and pharmacodynamics of cefquinome against Streptococcus agalactiae in a murine mastitis model.
Yang Q; Zhang C; Liu X; Zhang L; Yong K; Lv Q; Zhang Y; Chen L; Zhong P; Liu Y
PLoS One; 2023; 18(1):e0278306. PubMed ID: 36696421
[TBL] [Abstract][Full Text] [Related]
18. A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia.
Lood R; Raz A; Molina H; Euler CW; Fischetti VA
Antimicrob Agents Chemother; 2014 Jun; 58(6):3073-84. PubMed ID: 24637688
[TBL] [Abstract][Full Text] [Related]
19. A novel phage-encoded endolysin EN534-C active against clinical strain Streptococcus agalactiae GBS.
Bocanova L; Psenko M; Barák I; Halgasova N; Drahovska H; Bukovska G
J Biotechnol; 2022 Nov; 359():48-58. PubMed ID: 36179792
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte populations and cytokine expression in the mammary gland in a mouse model of Streptococcus agalactiae mastitis.
Trigo G; Dinis M; França Â; Bonifácio Andrade E; Gil da Costa RM; Ferreira P; Tavares D
J Med Microbiol; 2009 Jul; 58(Pt 7):951-958. PubMed ID: 19498204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
